Latest Takeda Pharmaceutical Company Stories
The Firm is filing Actos lawsuits on behalf of individuals who took Actos for an extended period of time and allegedly developed bladder cancer due to their use of the Type 2 diabetes medication.
Takeda Pharmaceuticals and marketing partner Eli Lilly & Co.
Takeda Pharmaceutical Co. and Eli Lilly & Co. must pay a total of $9 billion in punitive damages after they were found to have concealed diabetes drug, Actos’, cancer risks.
Takeda Pharmaceutical, Eli Lilly found liable for man's bladder cancer LAFAYETTE, La., April 8, 2014 /PRNewswire/ -- A Louisiana jury has awarded $9 billion to a New York man and his
INDIANAPOLIS, April 8, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) issued the following statement today in response to the verdict in the case of Terrence Allen, et al. v.
DEERFIELD, Ill., April 8, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced that in the case of Terrence Allen, et al. v.
A new lawsuit filed on March 17, by a woman in Missouri Eastern District Court alleges that her father died from bladder cancer as a result of ingesting Actos.
EMERYVILLE, Calif. and OSAKA, Japan, March 31, 2014 /PRNewswire/ -- Trianni, Inc.
Nevada case involves allegations that women developed cancer as a result of Actos medication.
An increased risk of bladder cancer may not be the only disease risk for people treated with the diabetes drug Actos. Raleigh, NC (PRWEB) March 21, 2014
- The parings of haberdine; also, any kind of fragments.